Clinical Trial Update: A Study of Aflibercept Versus Placebo With FOLFIRI in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing aflibercept plus FOLFIRI versus placebo plus FOLFIRI in metastatic colorectal cancer after oxaliplatin exposure. The study is completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• Zaltrap (ramucirumab)

Snippet

Sponsor: Sanofi | Conditions: Colorectal Cancer Metastatic | Phase 3 | Status: COMPLETED | Results posted: 2015-11-26